CSG’s Production Data Blitz Fails to Fully Reassure as Shares Languish Below IPO Price

Czech defence group CSG NV faces a record stock low amid short-seller claims, but strong fundamentals and analyst buy ratings suggest a disconnect.

The gap between operational strength and market sentiment at Czech defence group CSG NV has rarely been wider. While the company’s order book bulges at over €15 billion and its adjusted operating margin sits at a punchy 24.1%, the stock has been battered to levels that tell a very different story. A short-seller assault from Hunterbrook Media has only deepened the disconnect, forcing management into an unusually detailed rebuttal.

Hunterbrook’s report questioned the group’s ammunition production capacity, prompting an immediate response from Prague. The company dismissed the claims as a fundamental misunderstanding of its manufacturing model, pointing out that output is spread across multiple sites rather than concentrated at a single location. To underscore its point, CSG published granular production figures for the first time: roughly 630,000 large-calibre rounds were manufactured last year, with a 20% capacity increase planned for 2026. A new production line in Slovakia is expected to provide the additional firepower, with the company targeting an eventual in-house capacity of 1.1 million rounds.

The share price has clawed back some ground, rising 4.57% on Wednesday to €16.84, but that still leaves it deep in the red. The stock hit a record low of €15.73 earlier in the week — a 52-week trough — and remains far below its January IPO price of €25 on the Amsterdam exchange. Over the past month alone, the equity has shed roughly 37% of its value.

Management is also pushing back against speculation that a potential ceasefire in Ukraine could derail the defence boom. A halt to hostilities, the company argues, would not destroy orders but merely shift demand from ammunition to broader modernisation programmes. The structural drivers of European rearmament and alignment with NATO standards remain firmly in place.

On the financial front, the picture is more reassuring. Moody’s upgraded the credit rating on CSG’s secured debt to investment-grade Baa3 in February, while JPMorgan analysts have praised the group’s “extremely solid” balance sheet. They expect net debt to fall to 0.7 times operating earnings by the end of 2026. All nine analysts covering the stock rate it a buy, with a consensus price target of €35.40.

Investors will get their first proper look at the company’s post-IPO financials on 20 May, when CSG reports first-quarter results. The report will include the retrospectively booked costs of the listing itself, adding a layer of complexity to the numbers. Until then, the market remains caught between a robust operational reality and a share price that has yet to reflect it.